{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:09:32Z","timestamp":1777039772754,"version":"3.51.4"},"reference-count":76,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"name":"Sichuan Medical And Health Care Promotion Institute of China","award":["KY2022QN0245"],"award-info":[{"award-number":["KY2022QN0245"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>The aim of this study was to investigate the potential of dihydroartemisinin\nto augment the efficacy of cisplatin chemotherapy through the modulation of LASS2\nexpression.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>TCMSP, CTR-DB, TCGA-BLC, and other databases were used to analyze the possibility\nof LASS2 as the target gene of dihydroartemisinin. Cell experiments revealed the synergistic\neffect of DDP and DHA. Animal experiments showed that DHA inhibited the growth of\nDDP-treated mice. In addition, WB, real-time PCR, and immunohistochemical analysis showed\nthat DHA enhanced LASS2 (CERS2) expression in bladder cancer cells and DDP-treated mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>LASS2 is associated with cisplatin chemosensitivity.LASS2 expression levels are different\nbetween BLC tissues and normal tissues. COX analysis showed that patients with high\nLASS2 expression had a higher cumulative overall survival rate than those with low LASS2\nexpression. The Sankey plot showed that LASS2 expression is lower in BLC tissues with more\nadvanced stage and distant metastasis. The docking score of DHA and LASS2 reached the maximum\nvalue of -5.5259, indicating that DHA had a strong binding affinity with LASS2 targets.\nCCK8 assay showed that the most effective concentration ratio of DHA to DDP was 2.5 \u03bcg\/ml +\n10\u03bcg\/ml. In vivo experiments showed that DHA inhibited tumor growth in cisplatin-treated mice.\nIn addition, WB, RT-qPCR, and immunohistochemical analysis showed that DHA was able to\nenhance LASS2 expression in BLC cells and DDP-treated mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The upregulation of LASS2 (CERS2) expression in bladder cancer cells by DHA\nhas been found to enhance cisplatin chemosensitivity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010305651240514100129","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:15:56Z","timestamp":1715937356000},"page":"525-538","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expression of LASS2 Can be Regulated by Dihydroartemisinin to Regulate Cisplatin Chemosensitivity in Bladder Cancer Cells"],"prefix":"10.2174","volume":"26","author":[{"given":"Xuhua","family":"Qiao","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Panzhihua University, Panzhihua Hospital of Chinese and Western Combination, Urology Basic\nand Clinical Research Team of Affiliated Hospital of Panzhihua University, Urology Research and Innovation Platform\nof Panzhihua City, Panzhihua, Sichuan 617000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongbo","family":"Xue","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Panzhihua University, Panzhihua Hospital of Chinese and Western Combination, Urology Basic\nand Clinical Research Team of Affiliated Hospital of Panzhihua University, Urology Research and Innovation Platform\nof Panzhihua City, Panzhihua, Sichuan 617000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Li","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Panzhihua University, Panzhihua Hospital of Chinese and Western Combination, Urology Basic\nand Clinical Research Team of Affiliated Hospital of Panzhihua University, Urology Research and Innovation Platform\nof Panzhihua City, Panzhihua, Sichuan 617000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Panzhihua University, Panzhihua Hospital of Chinese and Western Combination, Urology Basic\nand Clinical Research Team of Affiliated Hospital of Panzhihua University, Urology Research and Innovation Platform\nof Panzhihua City, Panzhihua, Sichuan 617000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chundong","family":"Ji","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Panzhihua University, Panzhihua Hospital of Chinese and Western Combination, Urology Basic and Clinical Research Team of Affiliated Hospital of Panzhihua University, Urology Research and Innovation Platform of Panzhihua City, Panzhihua, Sichuan 617000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"459","volume":"43","author":"Lin H.Y.","year":"2021","unstructured":"Lin H.Y.; Wang X.; He C.; Zhou Z.L.; Yang M.K.; Wen Z.L.; Han H.W.; Lu G.H.; Qi J.L.; Yang Y.H.; Progress on biosynthesis and function of the natural products of Zi Cao as a traditional Chinese medicinal herb. Yi Chuan  2021,43(5),459-472","journal-title":"Yi Chuan"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"115387","DOI":"10.1016\/j.jep.2022.115387","volume":"294","author":"Gao L.","year":"2022","unstructured":"Gao L.; Li H.; Li B.; Traditional uses, phytochemistry, transformation of ingredients and pharmacology of the dried seeds of Raphanus sativus L. (Raphani Semen), A comprehensive review. J Ethnopharmacol  2022,294,115387","journal-title":"J Ethnopharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12094-021-02716-4","volume":"24","author":"Wei J.","year":"2022","unstructured":"Wei J.; Liu Z.; He J.; Liu Q.; Lu Y.; He S.; Yuan B.; Zhang J.; Ding Y.; Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism. Clin Transl Oncol  2022,24(3),471-482","journal-title":"Clin Transl Oncol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-3-030-64872-5_22","volume":"1308","author":"Mohtashami L.","year":"2021","unstructured":"Mohtashami L.; Amiri M.S.; Ayati Z.; Ethnobotanical uses, phytochemistry and pharmacology of different rheum species (Polygonaceae): A review. Adv Exp Med Biol  2021,1308,309-352","journal-title":"Adv Exp Med Biol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12885-020-07256-8","volume":"20","author":"Mansouri K.","year":"2020","unstructured":"Mansouri K.; Rasoulpoor S.; Daneshkhah A.; Abolfathi S.; Salari N.; Mohammadi M.; Rasoulpoor S.; Shabani S.; Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer  2020,20(1),791","journal-title":"BMC Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40199-020-00331-2","volume":"28","author":"Matloubi Z.","year":"2020","unstructured":"Matloubi Z.; Hassan Z.; HSA-curcumin nanoparticles: A promising substitution for curcumin as a cancer chemoprevention and therapy. Daru  2020,28(1),209-219","journal-title":"Daru"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/ptr.7699","volume":"37","author":"Boretti A.","year":"2023","unstructured":"Boretti A.; Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand. Phytother Res  2023,37(4),1227-1231","journal-title":"Phytother Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.3390\/ijms24032952","volume":"24","author":"Maugeri A.","year":"2023","unstructured":"Maugeri A.; Calderaro A.; Patan\u00e8 G.T.; Navarra M.; Barreca D.; Cirmi S.; Felice M.R.; Targets involved in the anti-cancer activity of quercetin in breast, colorectal and liver neoplasms. Int J Mol Sci  2023,24(3),2952","journal-title":"Int J Mol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"115000","DOI":"10.1016\/j.ejmech.2022.115000","volume":"247","author":"Zeng Z.W.","year":"2023","unstructured":"Zeng Z.W.; Chen D.; Chen L.; A comprehensive overview of Artemisinin and its derivatives as anticancer agents. Eur J Med Chem  2023,247,115000","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1142\/S0192415X24500071","volume":"52","author":"Wang Y.","year":"2024","unstructured":"Wang Y.; Yuan X.; Ren M.; Wang Z.; Ferroptosis: A new research direction of artemisinin and its derivatives in anti-cancer treatment. Am J Chin Med  2024,52(1),161-181","journal-title":"Am J Chin Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"155156","DOI":"10.1016\/j.phymed.2023.155156","volume":"122","author":"Wang J.","year":"2024","unstructured":"Wang J.; Zhang J.; Guo Z.; Targeting HSP70 chaperones by rhein sensitizes liver cancer to artemisinin derivatives. Phytomedicine  2024,122,155156","journal-title":"Phytomedicine"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1002\/ange.201601967","volume":"128","author":"Tu Y.","year":"2016","unstructured":"Tu Y.; Artemisinin: Ein Geschenk der traditionellen chinesischen Medizin an die Welt (Nobel\u2010Aufsatz). Angew Chem  2016,128(35),10366-10382","journal-title":"Angew Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"107658","DOI":"10.1016\/j.pharmthera.2020.107658","volume":"216","author":"Ma N.","year":"2020","unstructured":"Ma N.; Zhang Z.; Liao F.; The birth of artemisinin. PHARMACOL THERAPEUT  2020,216,107658","journal-title":"PHARMACOL THERAPEUT"},{"key":"ref=14","first-page":"2876","volume":"48","author":"Gao X.N.","year":"2023","unstructured":"Gao X.N.; Kang J.J.; Sun P.; Zhao Y.F.; Zhang D.; Yang L.; Ma Y.; Gao H.M.; Microbial transformation of artemisinin and its derivatives. Zhongguo Zhongyao Zazhi  2023,48(11),2876-2895","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40249-023-01152-6","volume":"12","author":"Huang Y.","year":"2023","unstructured":"Huang Y.; Yang Y.; Liu G.; Xu M.; New clinical application prospects of artemisinin and its derivatives: A scoping review. Infect Dis Poverty  2023,12(1),115","journal-title":"Infect Dis Poverty"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.7150\/ijbs.50364","volume":"17","author":"Dai X.","year":"2021","unstructured":"Dai X.; Zhang X.; Chen W.; Chen Y.; Zhang Q.; Mo S.; Lu J.; Dihydroartemisinin: A potential natural anticancer drug. Int J Biol Sci  2021,17(2),603-622","journal-title":"Int J Biol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jphs.2021.02.001","volume":"146","author":"Zheng J.","year":"2021","unstructured":"Zheng J.; Li X.; Yang W.; Zhang F.; Dihydroartemisinin regulates apoptosis, migration, and invasion of ovarian cancer cells via mediating RECK. J Pharmacol Sci  2021,146(2),71-81","journal-title":"J Pharmacol Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"9573","DOI":"10.1039\/D0FO00996B","volume":"11","author":"Gao J.","year":"2020","unstructured":"Gao J.; Ma F.; Wang X.; Li G.; Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration via regulation of the DLC1\/TCTP\/Cdc42 pathway. Food Funct  2020,11(11),9573-9584","journal-title":"Food Funct"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40360-021-00542-6","volume":"23","author":"Xiao L.","year":"2022","unstructured":"Xiao L.; Xu C.; Lin P.; Mu L.; Yang X.; Novel dihydroartemisinin derivative Mito-DHA5 induces apoptosis associated with mitochondrial pathway in bladder cancer cells. BMC Pharmacol Toxicol  2022,23(1),10","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.7150\/jca.36174","volume":"11","author":"Wang T.","year":"2020","unstructured":"Wang T.; Luo R.; Li W.; Yan H.; Xie S.; Xiao W.; Wang Y.; Chen B.; Bai P.; Xing J.; Dihydroartemisinin suppresses bladder cancer cell invasion and migration by regulating KDM3A and p21. J Cancer  2020,11(5),1115-1124","journal-title":"J Cancer"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2174\/1389201022666210217114825","volume":"23","author":"Zhang S.","year":"2022","unstructured":"Zhang S.; Feng R.; Yuan F.; Luo Q.; Chen X.; Li N.; Yang S.; The therapeutic effects of dihydroartemisinin on cisplatin-resistant gastric cancer cells. Curr Pharm Biotechnol  2022,23(2),276-286","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"596788","DOI":"10.3389\/fcell.2020.596788","volume":"8","author":"Cui W.","year":"2020","unstructured":"Cui W.; Fang T.; Duan Z.; Dihydroartemisinin sensitizes esophageal squamous cell carcinoma to cisplatin by inhibiting sonic hedgehog signaling. Front Cell Dev Biol  2020,8,596788","journal-title":"Front Cell Dev Biol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/ol.2022.13395","volume":"24","author":"Rao Q.","year":"2022","unstructured":"Rao Q.; Li R.; Yu H.; Xiang L.; He B.; Wu F.; Zhao G.; Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells. Oncol Lett  2022,24(2),275","journal-title":"Oncol Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41419-021-03996-y","volume":"12","author":"Du J.","year":"2021","unstructured":"Du J.; Wang X.; Li Y.; Ren X.; Zhou Y.; Hu W.; Zhou C.; Jing Q.; Yang C.; Wang L.; Li H.; Fang L.; Zhou Y.; Tong X.; Wang Y.; DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Cell Death Dis  2021,12(7),705","journal-title":"Cell Death Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1142\/S0192415X23500234","volume":"51","author":"Zhang J.","year":"2023","unstructured":"Zhang J.; Li Y.; Wang J.G.; Feng J.Y.; Huang G.D.; Luo C.G.; Dihydroartemisinin affects STAT3\/DDA1 signaling pathway and reverses breast cancer resistance to cisplatin. Am J Chin Med  2023,51(2),445-459","journal-title":"Am J Chin Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"100991","DOI":"10.1016\/j.neo.2024.100991","volume":"51","author":"Ni L.","year":"2024","unstructured":"Ni L.; Zhu X.; Zhao Q.; Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways. Neoplasia  2024,51,100991","journal-title":"Neoplasia"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/iub.319","volume":"62","author":"Levy M.","year":"2010","unstructured":"Levy M.; Futerman A.H.; Mammalian ceramide synthases. IUBMB Life  2010,62(5),347-356","journal-title":"IUBMB Life"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/978-1-4419-6741-1_4","volume":"688","author":"Stiban J.","year":"2010","unstructured":"Stiban J.; Tidhar R.; Futerman A.H.; Ceramide synthases: Roles in cell physiology and signaling. Adv Exp Med Biol  2010,688,60-71","journal-title":"Adv Exp Med Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.bbalip.2013.12.003","volume":"1841","author":"Taniguchi M.","year":"2014","unstructured":"Taniguchi M.; Okazaki T.; The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration\u2014from cell and animal models to human disorders. Biochim Biophys Acta Mol Cell Biol Lipids  2014,1841(5),692-703","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"151337","DOI":"10.1016\/j.ejcb.2023.151337","volume":"102","author":"Alizadeh J.","year":"2023","unstructured":"Alizadeh J.; da Silva Rosa S.C.; Weng X.; Jacobs J.; Lorzadeh S.; Ravandi A.; Vitorino R.; Pecic S.; Zivkovic A.; Stark H.; Shojaei S.; Ghavami S.; Ceramides and ceramide synthases in cancer: Focus on apoptosis and autophagy. Eur J Cell Biol  2023,102(3),151337","journal-title":"Eur J Cell Biol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.3390\/cancers13102475","volume":"13","author":"Sheridan M.","year":"2021","unstructured":"Sheridan M.; Ogretmen B.; The role of ceramide metabolism and signaling in the regulation of mitophagy and cancer therapy. Cancers (Basel)  2021,13(10),2475","journal-title":"Cancers (Basel)"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.plipres.2019.04.002","volume":"74","author":"Brachtendorf S.","year":"2019","unstructured":"Brachtendorf S.; El-Hindi K.; Gr\u00f6sch S.; Ceramide synthases in cancer therapy and chemoresistance. Prog Lipid Res  2019,74,160-185","journal-title":"Prog Lipid Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13402-023-00798-6","volume":"46","author":"Zhang M.","year":"2023","unstructured":"Zhang M.; Li Z.; Liu Y.; Ding X.; Wang Y.; Fan S.; The ceramide synthase (CERS\/LASS) family: Functions involved in cancer progression. Cell Oncol  2023,46(4),825-845","journal-title":"Cell Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.canlet.2021.06.024","volume":"522","author":"Qi D.","year":"2021","unstructured":"Qi D.; Song X.; Xue C.; AKT1\/FOXP3 axis-mediated expression of CerS6 promotes p53 mutant pancreatic tumorigenesis. Cancer Lett  2021,522,105-118","journal-title":"Cancer Lett"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.2174\/0929867326666190911115722","volume":"27","author":"Grb\u010di\u0107 P.","year":"2020","unstructured":"Grb\u010di\u0107 P.; Car E.P.M.; Sedi\u0107 M.; Targeting ceramide metabolism in hepatocellular carcinoma: New points for therapeutic intervention. Curr Med Chem  2020,27(39),6611-6627","journal-title":"Curr Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41419-020-03281-4","volume":"12","author":"Trayssac M.","year":"2021","unstructured":"Trayssac M.; Clarke C.J.; Stith J.L.; Snider J.M.; Newen N.; Gault C.R.; Hannun Y.A.; Obeid L.M.; Targeting sphingosine kinase 1 (SK1) enhances oncogene-induced senescence through ceramide synthase 2 (CerS2)-mediated generation of very-long-chain ceramides. Cell Death Dis  2021,12(1),27","journal-title":"Cell Death Dis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"33549","DOI":"10.1074\/jbc.M109.031971","volume":"284","author":"Imgrund S.","year":"2009","unstructured":"Imgrund S.; Hartmann D.; Farwanah H.; Eckhardt M.; Sandhoff R.; Degen J.; Gieselmann V.; Sandhoff K.; Willecke K.; Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas. J Biol Chem  2009,284(48),33549-33560","journal-title":"J Biol Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e21287","DOI":"10.1096\/fj.202001504RR","volume":"35","author":"Zhang X.","year":"2021","unstructured":"Zhang X.; Sakamoto W.; Canals D.; Ishibashi M.; Matsuda M.; Nishida K.; Toyoshima M.; Shigeta S.; Taniguchi M.; Senkal C.E.; Okazaki T.; Yaegashi N.; Hannun Y.A.; Nabe T.; Kitatani K.; Ceramide synthase 2\u2010C 24:1 \u2010ceramide axis limits the metastatic potential of ovarian cancer cells. FASEB J  2021,35(2),e21287","journal-title":"FASEB J"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3892\/etm.2013.892","volume":"5","author":"Zhao Q.","year":"2013","unstructured":"Zhao Q.; Wang H.; Yang M.; Yang D.; Zuo Y.; Wang J.; Expression of a tumor-associated gene, LASS2, in the human bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3. Exp Ther Med  2013,5(3),942-946","journal-title":"Exp Ther Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.7754\/Clin.Lab.2017.171026","volume":"64","author":"Luan T.","year":"2018","unstructured":"Luan T.; Zou R.; Huang L.; Li N.; Fu S.; Huang Y.; Wang H.; Wang J.; Hsa-miR-3658 promotes cell proliferation, migration and invasion by effecting LASS2 in bladder cancer. Clin Lab  2018,64(04\/2018),515-525","journal-title":"Clin Lab"},{"key":"ref=41","first-page":"1813","volume":"9","author":"Liu J.","year":"2016","unstructured":"Liu J.; Wang H.; Wang Y.; Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2. OncoTargets Ther  2016,9,1813-1822","journal-title":"OncoTargets Ther"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"9631","DOI":"10.1007\/s13277-015-3713-7","volume":"36","author":"Wang H.","year":"2015","unstructured":"Wang H.; Zhang W.; Zuo Y.; Ding M.; Ke C.; Yan R.; Zhan H.; Liu J.; Wang J.; miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer. Tumour Biol  2015,36(12),9631-9640","journal-title":"Tumour Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.7150\/jca.23087","volume":"9","author":"Huang L.","year":"2018","unstructured":"Huang L.; Luan T.; Chen Y.; Bao X.; Huang Y.; Fu S.; Wang H.; Wang J.; LASS2 regulates invasion and chemoresistance via ERK\/Drp1 modulated mitochondrial dynamics in bladder cancer cells. J Cancer  2018,9(6),1017-1024","journal-title":"J Cancer"},{"key":"ref=44","first-page":"769","volume":"10","author":"Hu Q.","year":"2017","unstructured":"Hu Q.; Wang Z.; Chao N.; Advances in the mechanisms of resistance to platinum-based antineoplastic drugs. Advances in Pharmacy  2017,10,769-774","journal-title":"Advances in Pharmacy"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","volume":"21","author":"Rottenberg S.","year":"2021","unstructured":"Rottenberg S.; Disler C.; Perego P.; The rediscovery of platinum-based cancer therapy. Nat Rev Cancer  2021,21(1),37-50","journal-title":"Nat Rev Cancer"},{"key":"ref=46","first-page":"130","volume":"02","author":"Qiao X.","year":"2023","unstructured":"Qiao X.; Tan Z.; Shi F.; The inhibitory effect of dihydroartemisinin combined with cisplatin on the proliferation of bladder cancer cells. Chongqing Yike Daxue Xuebao  2023,02,130-135","journal-title":"Chongqing Yike Daxue Xuebao"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"Livak K.J.","year":"2001","unstructured":"Livak K.J.; Schmittgen T.D.; Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method Methods  2001,25(4),402-408","journal-title":"Method Methods"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1332213","DOI":"10.3389\/fimmu.2023.1332213","volume":"14","author":"Huang S.","year":"2023","unstructured":"Huang S.; Huang Y.; Li C.; Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: A systematic review and meta-analysis. Front Immunol  2023,14,1332213","journal-title":"Front Immunol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"Patel V.G.","year":"2020","unstructured":"Patel V.G.; Oh W.K.; Galsky M.D.; Treatment of muscle\u2010invasive and advanced bladder cancer in 2020. CA Cancer J Clin  2020,70(5),404-423","journal-title":"CA Cancer J Clin"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2138957882","DOI":"10.1177\/0963689720965178","volume":"29","author":"Guo C.","year":"2020","unstructured":"Guo C.; Shao T.; Wei D.; Bioinformatic identification of potential hub genes in muscle-invasive bladder urothelial carcinoma. Cell Transplant  2020,29,2138957882","journal-title":"Cell Transplant"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ijc.32556","volume":"146","author":"Stroggilos R.","year":"2020","unstructured":"Stroggilos R.; Mokou M.; Latosinska A.; Makridakis M.; Lygirou V.; Mavrogeorgis E.; Drekolias D.; Frantzi M.; Mullen W.; Fragkoulis C.; Stasinopoulos K.; Papadopoulos G.; Stathouros G.; Lazaris A.C.; Makrythanasis P.; Ntoumas K.; Mischak H.; Zoidakis J.; Vlahou A.; Proteome\u2010based classification of nonmuscle invasive bladder cancer. Int J Cancer  2020,146(1),281-294","journal-title":"Int J Cancer"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S1166-7087(20)30751-X","volume":"30","author":"Roupr\u00eat M.","year":"2020","unstructured":"Roupr\u00eat M.; Pignot G.; Masson-Lecomte A.; Comp\u00e9rat E.; Audenet F.; Roumigui\u00e9 M.; Hou\u00e9d\u00e9 N.; Larr\u00e9 S.; Brunelle S.; Xylinas E.; Neuzillet Y.; M\u00e9jean A.; French ccAFU guidelines - update 2020-2022: Bladder cancer. Prog Urol  2020,30(12S),S78-S135","journal-title":"Prog Urol"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00120-020-01237-2","volume":"59","author":"Todenh\u00f6fer T.","year":"2020","unstructured":"Todenh\u00f6fer T.; Boegemann M.; Immunotherapy in bladder cancer-quo vadis? Update on current trials and developments. Urologe A  2020,59(7),810-816","journal-title":"Urologe A"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"Ghosh S.","year":"2019","unstructured":"Ghosh S.; Cisplatin: The first metal based anticancer drug. Bioorg Chem  2019,88,102925","journal-title":"Bioorg Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2147\/DDDT.S119488","volume":"11","author":"Ndagi U.","year":"2017","unstructured":"Ndagi U.; Mhlongo N.; Soliman M.E.; Metal complexes in cancer therapy - An update from drug design perspective. Drug Des Devel Ther  2017,11,599-616","journal-title":"Drug Des Devel Ther"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"e202300061","DOI":"10.1002\/cbdv.202300061","volume":"20","author":"Kumar Singh A.","year":"2023","unstructured":"Kumar Singh A.; Kumar A.; Singh H.; Sonawane P.; Pathak P.; Grishina M.; Pal Yadav J.; Verma A.; Kumar P.; Metal complexes in cancer treatment: Journey so far. Chem Biodivers  2023,20(4),e202300061","journal-title":"Chem Biodivers"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1021\/cr020010d","volume":"103","author":"Fuertes M.A.","year":"2003","unstructured":"Fuertes M.A.; Alonso C.; P\u00e9rez J.M.; Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev  2003,103(3),645-662","journal-title":"Chem Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"e2015808118","DOI":"10.1073\/pnas.2015808118","volume":"118","author":"Xiao Y.","year":"2021","unstructured":"Xiao Y.; Lin F.T.; Lin W.C.; ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer. Proc Natl Acad Sci USA  2021,118(3),e2015808118","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1186\/s12885-018-5218-4","volume":"18","author":"Li Y.","year":"2018","unstructured":"Li Y.; Zhang S.; Wang Y.; Peng J.; Fang F.; Yang X.; MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1\/c-Abl apoptosis signaling pathway. BMC Cancer  2018,18(1),1294","journal-title":"BMC Cancer"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"803114","DOI":"10.3389\/fphar.2022.803114","volume":"13","author":"Mahapatra E.","year":"2022","unstructured":"Mahapatra E.; Sengupta D.; Kumar R.; Phenethylisothiocyanate potentiates platinum therapy by reversing cisplatin resistance in cervical cancer. Front Pharmacol  2022,13,803114","journal-title":"Front Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.13005\/bpj\/1608","volume":"12","author":"Aldossary S.A.","year":"2019","unstructured":"Aldossary S.A.; Review on pharmacology of cisplatin: Clinical use, toxicity and mechanism of resistance of cisplatin. Biomed Pharmacol J  2019,12(1),7-15","journal-title":"Biomed Pharmacol J"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"112061","DOI":"10.1016\/j.yexcr.2020.112061","volume":"393","author":"Gong T.T.","year":"2020","unstructured":"Gong T.T.; Liu X.D.; Zhan Z.P.; Wu Q.J.; Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells. Exp Cell Res  2020,393(2),112061","journal-title":"Exp Cell Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"Witjes J.A.","year":"2021","unstructured":"Witjes J.A.; Bruins H.M.; Cathomas R.; Comp\u00e9rat E.M.; Cowan N.C.; Gakis G.; Hern\u00e1ndez V.; Linares Espin\u00f3s E.; Lorch A.; Neuzillet Y.; Rouanne M.; Thalmann G.N.; Veskim\u00e4e E.; Ribal M.J.; van der Heijden A.G.; European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines. Eur Urol  2021,79(1),82-104","journal-title":"Eur Urol"},{"key":"ref=64","author":"Qiao X.","year":"2022","unstructured":"Qiao X.;  Preliminary study on the effect of dihydroartemisinin combined with cisplatin on bladder cancer cells  2022","journal-title":"Preliminary study on the effect of dihydroartemisinin combined with cisplatin on bladder cancer cells"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/ijpvm.IJPVM_258_17","volume":"8","author":"Aghaei M.","year":"2017","unstructured":"Aghaei M.; Poupel F.; Movahedian A.; Jafari S.; Shahrestanaki M.; Dihydroartemisinin induces apoptosis in human bladder cancer cell lines through reactive oxygen species, mitochondrial membrane potential, and cytochrome C pathway. Int J Prev Med  2017,8(1),78","journal-title":"Int J Prev Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ejmech.2018.09.061","volume":"159","author":"Ma X.","year":"2018","unstructured":"Ma X.; Hu M.; Wang H.; Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance. Eur J Med Chem  2018,159,381-392","journal-title":"Eur J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2174\/1389201020666190611124644","volume":"20","author":"Li N.","year":"2019","unstructured":"Li N.; Zhang S.; Luo Q.; Yuan F.; Feng R.; Chen X.; Yang S.; The effect of dihydroartemisinin on the malignancy and epithelial-mesenchymal transition of gastric cancer cells. Curr Pharm Biotechnol  2019,20(9),719-726","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.3390\/molecules28083407","volume":"28","author":"Coffetti G.","year":"2023","unstructured":"Coffetti G.; Moraschi M.; Facchetti G.; Rimoldi I.; The challenging treatment of cisplatin-resistant tumors: State of the art and future perspectives. Molecules  2023,28(8),3407","journal-title":"Molecules"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s12032-011-0026-6","volume":"29","author":"Wang H.","year":"2012","unstructured":"Wang H.; Wang J.; Zuo Y.; Ding M.; Yan R.; Yang D.; Ke C.; Expression and prognostic significance of a new tumor metastasis suppressor gene LASS2 in human bladder carcinoma. Med Oncol  2012,29(3),1921-1927","journal-title":"Med Oncol"},{"key":"ref=70","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.201030","volume":"67","author":"Xiao S.","year":"2021","unstructured":"Xiao S.; Chen Y.; Luan T.; Huang Y.; Fu S.; Zuo Y.; Wang H.; Wang J.; MicroRNA-20a targeting LASS2 promotes the proliferation, invasiveness and migration of bladder cancer. Clin Lab  2021,67(08)","journal-title":"Clin Lab"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3892\/ol.2016.5514","volume":"13","author":"Wang H.","year":"2017","unstructured":"Wang H.; Zuo Y.; Ding M.; Ke C.; Yan R.; Zhan H.; Liu J.; Wang W.; Li N.; Wang J.; LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity. Oncol Lett  2017,13(2),661-668","journal-title":"Oncol Lett"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"15668","DOI":"10.3390\/ijms242115668","volume":"24","author":"Garcia-Vallicrosa C.","year":"2023","unstructured":"Garcia-Vallicrosa C.; Falcon-Perez J.M.; Royo F.; The role of longevity assurance homolog 2\/ceramide synthase 2 in bladder cancer. Int J Mol Sci  2023,24(21),15668","journal-title":"Int J Mol Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.gene.2019.02.083","volume":"701","author":"Fu S.","year":"2019","unstructured":"Fu S.; Luan T.; Jiang C.; miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2. Gene  2019,701,23-31","journal-title":"Gene"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/1389201020666190328115411","volume":"20","author":"Yang B.","year":"2019","unstructured":"Yang B.; Mao J.; Gao B.; Lu X.; Computer-assisted drug virtual screening based on the natural product databases. Curr Pharm Biotechnol  2019,20(4),293-301","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/molecules25030627","volume":"25","author":"Ain Q.","year":"2020","unstructured":"Ain Q.; Batool M.; Choi S.; TLR4-targeting therapeutics: Structural basis and computer-aided drug discovery approaches. Molecules  2020,25(3),627","journal-title":"Molecules"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ijfs.14325","volume":"55","author":"Tao X.","year":"2020","unstructured":"Tao X.; Huang Y.; Wang C.; Chen F.; Yang L.; Ling L.; Che Z.; Chen X.; Recent developments in molecular docking technology applied in food science: A review. Int J Food Sci Technol  2020,55(1),33-45","journal-title":"Int J Food Sci Technol"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010305651240514100129","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/230002\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010305651240514100129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T12:59:08Z","timestamp":1739451548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/230002\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010305651240514100129","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}